Dr. Joshua Tobias holds a permanent position as a senior scientist and is a project and team leader at the Medical University of Vienna. He has 20 years of experience in microbiology, molecular biology, and the construction of clinically evaluated peptide- and protein-based vaccines against infectious diseases and cancer. For the last 10 years, his work has resulted in several B-cell peptide/mimotope-based cancer vaccine candidates and several peer-reviewed original and review articles (see references).
Patents
Department of Microbiology and Immunology, University of Gothenburg, Sweden
1. Vaccine for protection against ETEC-induced diarrhea comprising dmLT. US 2015/0320850 A1 2. Method for increasing ETEC CS6 antigen presentation on cell surface and products obtainable thereof. WO 2013/037718 Al 3. Hybrid operon for expression of colonization factor (CF) antigens of enterotoxigenic E. coli. WO 2009/004002 Al
Patent
Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology a
A method of producing a vaccine composition and uses thereof. WO 2019/153042 A1